MD Complete Breakout Treatment — Class II drug recall D-0091-2021
Terminated recall by Milbar Laboratories, Inc., reported 2020-11-25, distributed nationwide. GMP Deviations
| Recall number | D-0091-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Milbar Laboratories, Inc., East Haven, CT, United States |
| Recall initiated | 2020-10-09 |
| Classified | 2020-11-17 |
| Reported by FDA | 2020-11-25 |
| Terminated | 2023-01-04 |
| Distributed | Nationwide (US) |
| Quantity | 2,655 bottles |
| Reason classes | cgmp |
| Lot numbers | APR-23, DX278 |
Product
MD Complete Breakout Treatment (Benzoyl Peroxide 4.5%) 1 fl. oz. (30mL) bottles, MD Professional LLC, Minneapolis, MN
Reason for recall
GMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0091-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.